Christopher Weight, MD
Urology · Minneapolis, MNNPI 1962612127
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (47.0%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Eisai Inc. at 47.0% of the total. Among urology clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 29 payments — averaging $560.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$8K
- Abbott$6K
- Histosonics, Inc.$982
- EDAP Technomed Inc$744
- Janssen Scientific Affairs, LLC$196
- Intuitive Surgical$146
- plus $89 from 3 others
Across 1 payment — averaging $352.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Urogen Pharma, Inc.$352
What the payments were for
- Consulting fees$7,62647%
- Speaking & faculty fees$5,95037%
- Travel & lodging$1,2658%
- Food & beverage$1,4009%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 2 | $7,626 |
| Abbott | 3 | $6,458 |
| Histosonics, Inc. | 2 | $982 |
| EDAP Technomed Inc | 13 | $744 |
| Janssen Scientific Affairs, LLC | 2 | $196 |
| Intuitive Surgical | 2 | $146 |
| Johnson & Johnson | 3 | $45 |
| Ferring Pharmaceuticals Inc. | 1 | $25 |
| Koelis Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LENVIMA$7,626
- RealTime BRAF$6,450
- Erleada$149
- Da Vinci Surgical System$131
How this compares
$16,241 in reported general payments places this provider in the 90th percentile of 247 urology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 20 | $162 |
| Finasteride | 14 | $99 |
| Sildenafil Citrate | 11 | $20 |
Paid to pharmacies, not to this prescriber.
Other urology in Minneapolis
- Ayman SoubraMinneapolis$204K
- Sean ElliottMinneapolis$163K
- Nissrine NakibMinneapolis$86K
- Travis PagliaraMinneapolis$53K
- Badrinath KonetyMinneapolis$45K
- James AndersonMinneapolis$5K
- Joseph AcquayeMinneapolis$4K
- Joseph PariserMinneapolis$4K
- David YangMankato$298K
- Steven BernsteinEdina$271K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.